CUL4B orchestrates mesenchymal stem cell commitment by epigenetically repressing KLF4 and C/EBPδ.

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Mesenchymal stem cell (MSC) lineage commitment is vital for bone health, and its dysregulation is implicated in osteoporosis and aging.
• The precise molecular mechanisms governing MSC commitment, particularly the balance between osteogenesis and adipogenesis, are not fully understood.

Purpose of the Study:

• To identify and characterize novel regulators of mesenchymal stem cell (MSC) commitment.
• To elucidate the role of Cullin 4B (CUL4B) in regulating osteogenesis and adipogenesis in MSCs.

Main Methods:

• Conditional knockout mouse models were used to assess the in vivo function of Cullin 4B (CUL4B) in mesenchymal stem cells (MSCs).
• In vitro studies involving MSCs were performed to investigate the molecular mechanisms by which CUL4B regulates gene expression.
• Chromatin immunoprecipitation (ChIP) assays were employed to determine the direct binding of the CUL4B complex to target gene promoters.

Main Results:

• Cullin 4B (CUL4B) expression decreases with age in bone marrow MSCs (BMSCs) from mice and humans.
• Conditional knockout of CUL4B in MSCs led to impaired skeletal development, reduced bone mass, and decreased bone formation.
• CUL4B deficiency exacerbated age-related bone loss and marrow adipose tissue accumulation, and reduced bone strength.
• CUL4B epigenetically repressed KLF4 and C/EBPδ expression, thereby promoting osteogenesis and inhibiting adipogenesis.

Conclusions:

• Cullin 4B (CUL4B) is a critical epigenetic regulator of mesenchymal stem cell (MSC) lineage commitment.
• CUL4B promotes osteogenesis while inhibiting adipogenesis by repressing KLF4 and C/EBPδ.
• Targeting CUL4B may offer a therapeutic strategy for treating osteoporosis and age-related bone loss.